Therapeutic window for treatment of prion disease defined by timed depletion of Prion protein
Bradford, B. M.; Marshall, A.; Tuzi, N. L.; Kisielewski, D.; Summers, K. M.; Perry, V. H.; Piccardo, P.; Clarke, A. R.; Manson, J. C.
Show abstract
There is no effective treatment preventing the progression of neurodegenerative diseases such as prion and Alzheimers diseases. These fatal diseases of the central nervous system, involve progressive accumulation of a misfolded protein long before overt clinical signs of disease. Removal of prion protein early in the pathological process appears to halt the progression however, it is not known whether intervention at later disease stages could be effective. We investigated the potential for intervention throughout the course of prion disease, by developing a mouse model in which Prnp expression can be manipulated in a tissue specific and time dependent manner. Depleting Prnp from neuronal populations in CNS throughout the preclinical phase substantially prolonged incubation. The pathology was dramatically altered to a pattern of astrocytic associated prion deposition. However once overt clinical symptoms of disease were apparent Prnp depletion did not alter disease progression. This study establishes a wide window for intervention, and suggests timely treatment could delay the onset of clinical disease potentially well beyond the lifetime of an individual.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The Brain Interactome of a Permissive Prion Replication Substrate 93%
- Neuropathology in an α-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein 92%
- Cortico-amygdala synaptic structural abnormalities produced by templated aggregation of α-synuclein 92%
Similar papers in this journal
- Microglia-specific NF-κB signaling is a critical regulator of prion-induced glial inflammation and neuronal loss 94%
- Resolving Inflammation: The Impact of Antiretroviral Therapy on Macrophage Traffic In and Out of the CNS. 93%
- Simultaneous pathway engagement of translation in astrocytes, circadian rhythm in GABAergic neurons and cytoskeleton in glutamatergic neurons precede electroencephalographic changes in neurodegenerative prion disease 92%
Similar papers in this journal
- MRI-guided histology of TDP-43 knock-in mice implicates parvalbumin interneuron loss, impaired neurogenesis and aberrant neurodevelopment in ALS-FTD 92%
- Tau-mediated axonal degeneration is prevented by activation of the WldS pathway 91%
- Presynaptic accumulation of α-synuclein causes synaptopathy and progressive neurodegeneration 90%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.